Uloric FDA Approval History
FDA Approved: Yes (First approved February 13, 2009)
Brand name: Uloric
Generic name: febuxostat
Dosage form: Tablets
Company: Takeda Pharmaceutical Company Limited
Treatment for: Gout
Uloric (febuxostat) is a xanthine oxidase inhibitor indicated for the chronic management of hyperuricemia in patients with gout.
Development Timeline for Uloric
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.